Mapping the active site of factor Xa by selective inhibitors: An NMR and MD study
✍ Scribed by F. Fraternali; Q.-T. Do; B.-T. Doan; R.A. Atkinson; P. Palmas; V. Sklenar; P. Safar; P. Wildgoose; P. Strop; V. Saudek
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 504 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0887-3585
No coin nor oath required. For personal study only.
✦ Synopsis
The structure of two selective inhibitors, Ac-Tyr-Ile-Arg-Ile-Pro-NH 2 and Ac-(4-Amino-Phe)-(Cyclohexyl-Gly)-Arg-NH 2 , in the active site of the blood clotting enzyme factor Xa was determined by using transferred nuclear Overhauser effect nuclear magnetic resonance (NMR) spectroscopy. They represent a family of peptidic inhibitors obtained by the screening of a vast combinatorial library. Each structure was first calculated by using standard computational procedures (distance geometry, simulated annealing, energy minimization) and then further refined by systematic search of the conformation of the inhibitor docked in the active site and repeating the simulated annealing and energy minimization. The final structure was optimized by molecular dynamics simulations of the inhibitorcomplex in water. The NMR restraints were kept throughout the refinement. The inhibitors assume a compact, very well defined conformation, embedded into the substrate binding site not in the same way as a substrate, blocking thus the catalysis. The model allows to explain the mode of action, affinity, and specificity of the peptides and to map the active site.